Persistent left superior vena cava: A possible contraindication to chemotherapy and total parenteral nutrition in cancer patients

  • Authors:
    • Francesco Iovino
    • Pasquale Pio Auriemma
    • Luca Del Viscovo
    • Sara  Scagliarini
    • Marilena Di Napoli
    • Ferdinando De Vita
  • View Affiliations

  • Published online on: July 18, 2012     https://doi.org/10.3892/ol.2012.808
  • Pages: 759-762
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Persistent left superior vena cava (PLSVC) is the most common thoracic venous anomaly. Awareness of this condition may be useful when placement of left-side transvenous subclavian or internal jugular catheters is required. This anomaly may be detected only by chest radiograph following placement of the catheter. The primary endpoints of this study were to analyze the prevalence of PLSVC, measurement of its diameters and the outcome of cancer patients with this anomaly undergoing placement of a long term catheter for nutrition and chemotherapy at the Department of Surgery, of the Second University of Naples, Naples, Italy. A total of 600 consecutive adult patients with hematological or solid tumors admitted to our surgery department for implantation of a central venous catheter (CVC) were considered. The CVC was routinely implanted in the left internal jugular vein under ultrasound guidance. Four cases of PLSVC (0.6% of patients) were observed and confirmed using cine magnetic resonance imaging (MRI). In all cases, the CVC was not removed. Three patients underwent chemotherapy and one patient was subjected to total parenteral nutrition. In the three patients undergoing chemotherapy, dynamic ECG and echocardiography were performed at the end of the treatment. No disturbances of the cardiac rhythm or thrombosis were detected, and heart ejection fraction (EF) was not affected. In conclusion, although PLSVC may be a risky condition, no complications occurred in our study. Thus, PLSVC should not be regarded as a strict contraindication to infusion of chemotherapy or hyperosmolar nutritional solutions. However, further research is needed to confirm our data.
View Figures
View References

Related Articles

Journal Cover

October 2012
Volume 4 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Iovino F, Auriemma PP, Del Viscovo L, Scagliarini S, Di Napoli M and De Vita F: Persistent left superior vena cava: A possible contraindication to chemotherapy and total parenteral nutrition in cancer patients. Oncol Lett 4: 759-762, 2012
APA
Iovino, F., Auriemma, P.P., Del Viscovo, L., Scagliarini, S., Di Napoli, M., & De Vita, F. (2012). Persistent left superior vena cava: A possible contraindication to chemotherapy and total parenteral nutrition in cancer patients. Oncology Letters, 4, 759-762. https://doi.org/10.3892/ol.2012.808
MLA
Iovino, F., Auriemma, P. P., Del Viscovo, L., Scagliarini, S., Di Napoli, M., De Vita, F."Persistent left superior vena cava: A possible contraindication to chemotherapy and total parenteral nutrition in cancer patients". Oncology Letters 4.4 (2012): 759-762.
Chicago
Iovino, F., Auriemma, P. P., Del Viscovo, L., Scagliarini, S., Di Napoli, M., De Vita, F."Persistent left superior vena cava: A possible contraindication to chemotherapy and total parenteral nutrition in cancer patients". Oncology Letters 4, no. 4 (2012): 759-762. https://doi.org/10.3892/ol.2012.808